These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12661473)

  • 1. Inappropriate use of oral terbinafine in family practice.
    Wilcock M; Hartley J; Gould D
    Pharm World Sci; 2003 Feb; 25(1):25-6. PubMed ID: 12661473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine, a unique oral antifungal: current perceptions.
    Jain S; Sehgal VN
    Int J Dermatol; 2000 Jun; 39(6):412-23. PubMed ID: 10944085
    [No Abstract]   [Full Text] [Related]  

  • 3. Onychomycosis treated with a short course of oral terbinafine.
    Galimberti R; Kowalczuk A; Flores V; Squiquera L
    Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A questionnaire study on the management of onychomycosis: a Canadian perspective.
    Gupta AK; Shear NH
    Int J Dermatol; 1998 Jun; 37(6):457-60. PubMed ID: 9646138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis--treatment, relapse and re-infection.
    Hull PR
    Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia and pancytopenia associated with oral terbinafine.
    Kovacs MJ; Alshammari S; Guenther L; Bourcier M
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors for cure following treatment of onychomycosis.
    Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):679-84. PubMed ID: 19929941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis.
    Lebwohl MG; Daniel CR; Leyden J; Mormon M; Shavin JS; Tschen E; Weiss J; Zone J
    Int J Dermatol; 2001 May; 40(5):358-60. PubMed ID: 11555003
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis.
    Bahadir S; Inalöz HS; Alpay K; Agaoglu C; Cimsit G; Parlat P
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):422-3. PubMed ID: 11305391
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of terbinafine for toenail onychomycosis.
    Wallace GF
    J Am Podiatr Med Assoc; 2001; 91(10):542. PubMed ID: 11734613
    [No Abstract]   [Full Text] [Related]  

  • 14. Satisfaction with onychomycosis treatment. Pulse versus continuous dosing.
    Warshaw EM; Bowman T; Bodman MA; Kim JJ; Silva S; Mathias SD
    J Am Podiatr Med Assoc; 2003; 93(5):373-9. PubMed ID: 13130084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent.
    Goodfield MJ; Rowell NR; Forster RA; Evans EG; Raven A
    Br J Dermatol; 1989 Dec; 121(6):753-7. PubMed ID: 2532927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
    Ornstein DL; Ely P
    J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of oral antifungal agents to treat onychomycosis.
    Gupta AK; Ryder JE
    Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.